8-Methyl-6-nonenamide

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 8-Methyl-6-nonenamide
• 英文别名: (E)-8-methylnon-6-enamide
• 化学式: C₁₀H₁₉NO
• 分子量: 169.26
• InChiKey: YXENPUXPUOBZON-FNORWQNLSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  12
• 可旋转键数：
  6
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.7
• 拓扑面积：
  43.1
• 氢给体数：
  1
• 氢受体数：
  1

文献信息

• [EN] PRODRUGS OF PHENOLIC TRPV1 AGONISTS IN COMBINATION WITH LOCAL ANESTHETICS AND VASOCONSTRICTORS FOR IMPROVED LOCAL ANESTHESIA<br/>[FR] PROMÉDICAMENTS À BASE D'AGONISTES DE TRPV1 PHÉNOLIQUES EN ASSOCIATION AVEC DES ANESTHÉSIQUES LOCAUX ET DES VASOCONSTRICTEURS POUR AMÉLIORER UNE ANESTHÉSIE LOCALE
  申请人：CONCENTRIC ANALGESICS INC

  公开号：WO2017205534A1

  公开（公告）日：2017-11-30

  Described herein are compounds, pharmaceutical compositions and medicaments that include such compounds, and methods of using such compounds to modulate transient receptor potential vanilloid 1 receptor (TRPV1) activity.

  本文描述了包括这些化合物的化合物、药物组合物和药物，并使用这些化合物调节瞬时受体电位香草醛1受体（TRPV1）活性的方法。
• FUNGICIDAL 4-SUBSTITUTED-3--1,2,4-OXADIZOL-5(4H)-ONE DERIVATIVES
  申请人：Braun Christoph

  公开号：US20140349848A1

  公开（公告）日：2014-11-27

  The present invention provides fungicidal 4-substituted-3-phenyl[(heterocyclylmethoxy)imino]methyl}-1,2,4-oxadiazol-5(4H)-one derivatives of formula (I) wherein A represents a pyridyl or thiazole group and X1, Y1 to Y5 represent independently different substituents.

  本发明提供了式（I）的杀真菌4-取代-3- 苯基 [（杂环甲氧基）亚胺]甲基} -1,2,4-噁唑-5（4H）-酮衍生物，其中A代表吡啶基或噻唑基，X1，Y1至Y5分别代表不同的取代基。
• FUNGICIDAL 4-SUBSTITUTED-3-{PHENYL[(HETEROCYCLYLMETHOXY)IMINO]METHYL}-1,2,4-OXADIZOL-5(4H)-ONE DERIVATIVES
  申请人：Bayer Intellectual Property GmbH

  公开号：EP2755949B1

  公开（公告）日：2015-10-21
• PRODRUGS OF PHENOLIC TRPV1 AGONISTS
  申请人：Concentric Analgesics, Inc.

  公开号：EP3223805B1

  公开（公告）日：2021-02-24
• Compositions and methods for diagnosis of axial pain with or without radiculopathy
  申请人：McKay William F.

  公开号：US20080008988A1

  公开（公告）日：2008-01-10

  The invention provides methods and composition developed to be used with imaging techniques and useful for diagnosis and monitoring the pain generator(s) of axial pain with or without radiculopathy and methods for screening therapeutic compounds potentially useful for treating axial pain with or without radiculopathy. Alternatively, degenerated discs can be monitored and treated before occurrence of a pathological pain condition. Pain markers and markers of degeneration include markers of neuronal, vascular, immune and matrix elements.